‘Brain age’: Epigenetic biomarkers may help identify older patients at higher risk for earlier death
Springer | May 15, 2017

Some elderly people’s brains appear older than the age on their birth certificates. These people have a higher risk of developing deteriorating age-associated conditions and impairments, and even of experiencing an earlier death than expected.

The researchers first used machine-learning analysis techniques on neuroimaging data from a cohort of 2001 healthy people aged 18-90. This was then compared to the brain scans of 669 older adults who were part of the Lothian Birth Cohort 1936, a longitudinal study conducted in the Edinburgh and Lothians area of Scotland.

The study showed that it is possible to use neuroimaging assessments to establish a 73-year-old’s predicted age, and also to forecast whether that person will be dead by the age of 80. The research group further found that combining brain-predicted age with certain DNA-related epigenetic biomarkers of aging further improves predictions about a person’s probable mortality.

“Our study introduces a clinically relevant neuroimaging aging biomarker and demonstrates that combining distinct measures of biological aging further helps to determine risk of age-related deterioration and death,” Cole says, in summarizing the study’s value. “Such biomarkers could potentially identify those at risk of age-associated health problems years before symptoms appear, and be used as outcome measures in trials of therapeutics aimed at delaying the onset of age-related disease.”

[Read the full study here.]

The ELP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: What the age of your brain says about you

Want to stay up to date on the latest epigenetics news? Follow ELP on Twitter and like the Facebook

  • Mary Agh

    less immunogenic variants may enhance the ability of a tumour to bypass
    the host’s immune system. This process is referred to as tumour
    immunoediting. Interesting point.